Xencor | Nuværende Forpligtelser



Current Liabilities Lave om Dato
AbbVie USD 38.75B 4.31B 2024-12
Alnylam Pharmaceuticals USD 1.19B 34.39M 2024-12
Amgen USD 23.1B 2.79B 2024-12
Arrowhead Research USD 93.76M 9.41M 2024-12
AstraZeneca USD 27.87B 1.94B 2024-12
Biogen USD 5.53B 103.8M 2024-12
Bristol-Myers Squibb USD 23.77B 1.14B 2024-12
Cytokinetics USD 179.67M 69.86M 2024-12
GlaxoSmithKline GBP 21.7B 238M 2024-12
J&J USD 50.32B 1.44B 2024-12
MacroGenics USD 59.31M 1.4M 2024-09
Merck USD 28.42B 1.17B 2024-12
Novartis USD 28.69B 560M 2024-12
Pfizer USD 43B 216M 2024-12
Regeneron Pharmaceuticals USD 5.7B 2.04B 2024-12
Roche Holding CHF 27.02B 424M 2024-12
Xencor USD 87.43M 4.54M 2024-12



Xencor Nuværende Forpligtelser - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.